TXTMProText Mobility, Inc.
Price Chart
Loading chart...
About ProText Mobility, Inc. (TXTM)
ProText Mobility, Inc. (TXTM) is a Biotechnology company headquartered in Fort Lauderdale, FL, United States whose shares trade over-the-counter on the Pink tier.
Protext is a Biotech Company developing a Hemp/CBD -- Cannabis medicines platform for the legal cannabis industry, using proprietary live plant extraction processes & technologies. Through its wholly owned subsidiary RSAMMD Acquisitions LLC ("RSAMMDA") and under the leadership of its founders Mr. Dylon Du Plooy and Dr. Ahmed Jamaloodeen we partner with leading hospitals and universities globally to advance the clinical benefits and applications of cannabis. Mr. Du Plooy is a South African pioneer in the research and cultivation. Dr. J operates a 5000-hectare farm in New Castle, South Africa and holds hemp permit issued by the Government of South Africa, Department of Agriculture. Together the RSAMMDA founders have been at the forefront of medical cannabis legislation and South African cannabis legalization, which took place in September 2018. The company is committed to the advancement of technology and scientific research that leads to an improved quality of life for patients around the world.
Products and services
Company operates two wholly owned subsidiaries: Plandai Biotechnology South Africa (Pty) Ltd. and Cannabis Biosciences, Inc. The Company is engaged in the research, testing and commercialization of highly bioavailable botanical products-all-natural ingredients to be formulated for nutraceutical and/or pharmaceutical applications
TXTM key facts
- Ticker symbol
- TXTM
- Market tier
- Pink
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Fort Lauderdale, FL, United States
- Country of incorporation
- US
- Year of incorporation
- 2001
- Employees
- 10
- Estimated market cap
- $7.91M (as of Apr 10, 2025)
- Shares outstanding
- 8,791,221,631
- Reporting standard
- Alternative Reporting Standard
- Audit status
- Unaudited
- Fiscal year end
- 12/31
- Latest filing
- Quarterly Report (Sep 30, 2024)
ProText Mobility, Inc. leadership
- Dr. Ahmed Jamaloodeen — President
- Dylon Du Plooy — CEO
Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with T
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for ProText Mobility, Inc. (TXTM) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
More Biotechnology Companies on OTC Markets
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Company Leadership
Chief Executive Officer
Company Officers
Social Media
Business Details
Stock Details
Loading modules...